PS
LABD icon

PayPay Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

PayPay Securities’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
1,601
+447
+39% +$6.02K 0.3% 44
2026
Q1 		$15.7K Buy
1,154
+400
+53% +$7.57K 0.54% 45
2025
Q4 		$15.9K Buy
754
+430
+133% +$11.7K 0.47% 41
2025
Q3 		$13.1K Buy
324
+184
+131% +$10.7K 0.47% 34
2025
Q2 		$10.4K Buy
140
+22
+19% +$1.95K 0.51% 32
2025
Q1 		$11.1K Sell
118
-56
-32% -$4.1K 0.63% 35
2024
Q4 		$12.6K Buy
174
+115
+195% +$7.04K 0.55% 37
2024
Q3 		$3.47K Sell
59
-112
-65% -$6.8K 0.31% 74
2024
Q2 		$12.6K Sell
171
-101
-37% -$8.53K 1.05% 14
2024
Q1 		$19.8K Sell
272
-117
-30% -$9.76K 0.99% 18
2023
Q4 		$37.7K Buy
389
+195
+101% +$37.9K 1.85% 11
2023
Q3 		$40K Sell
194
-186
-49% -$30.2K 1.82% 11
2023
Q2 		$54.6K Buy
380
+290
+322% +$43.3K 3.35% 12
2023
Q1 		$18.6K Buy
+90
New +$15.3K 1.24% 15

Other funds holding LABD

CCM
Capstone Capital Management Hong Kong $224M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

PayPay Securities's LABD Position: Q2 2026 in Review

PayPay Securities increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 39% in Q2 2026, buying an estimated $6.02K and bringing the position to 1,601 shares worth $12.3K. The position accounts for 0.3% of the portfolio, ranked #44.

PayPay Securities first reported a position in LABD in Q1 2023 and has held it in 14 quarters since. The position peaked at $54.6K in Q2 2023. 3 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • PayPay Securities held 1,601 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $12.3K as of Q2 2026.
  • PayPay Securities bought 447 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $6.02K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up 0.3% of PayPay Securities's portfolio in Q2 2026, its #44 holding.
  • PayPay Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2023 and has held it in 14 quarters since.
  • PayPay Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $54.6K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.